Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

Similar articles for PubMed (Select 19789365)

1.

Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.

Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, Mosekilde L.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2655-60. doi: 10.1158/1055-9965.EPI-09-0531. Epub 2009 Sep 29.

2.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7.

3.

Calcium plus vitamin D supplementation and the risk of breast cancer.

Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2008 Nov 19;100(22):1581-91. doi: 10.1093/jnci/djn360. Epub 2008 Nov 11.

4.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

5.

Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.

McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE.

Breast Cancer Res. 2009;11(4):R64. doi: 10.1186/bcr2356. Epub 2009 Aug 28.

6.

Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study.

Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J.

Int J Cancer. 2010 Nov 1;127(9):2159-68. doi: 10.1002/ijc.25215.

PMID:
20112341
7.

Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.

Abbas S, Chang-Claude J, Linseisen J.

Int J Cancer. 2009 Jan 1;124(1):250-5. doi: 10.1002/ijc.23904.

PMID:
18839430
8.

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE.

J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9.

9.

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.

Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL, Ambrosone CB.

PLoS One. 2011 Feb 28;6(2):e17251. doi: 10.1371/journal.pone.0017251.

10.

Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.

McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE.

Breast Cancer Res. 2007;9(1):R9.

11.

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.

Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2003 Mar 5;95(5):373-80.

12.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

13.

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162.

14.

Intake of dairy products, calcium, and vitamin d and risk of breast cancer.

Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC.

J Natl Cancer Inst. 2002 Sep 4;94(17):1301-11.

15.

Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.

Agborsangaya CB, Surcel HM, Toriola AT, Pukkala E, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M.

Eur J Cancer. 2010 Feb;46(3):467-70. doi: 10.1016/j.ejca.2009.11.019.

PMID:
20022237
16.

Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy.

Rejnmark L, Lauridsen AL, Brot C, Vestergaard P, Heickendorff L, Nexo E, Mosekilde L.

Scand J Clin Lab Invest. 2006;66(3):227-38.

PMID:
16714251
17.

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.

Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2006 Oct 15;66(20):10213-9.

18.

Behavioural and physical characteristics associated with vitamin D status in women.

Pasco JA, Henry MJ, Nicholson GC, Brennan SL, Kotowicz MA.

Bone. 2009 Jun;44(6):1085-91. doi: 10.1016/j.bone.2009.02.020. Epub 2009 Mar 2.

PMID:
19264157
19.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8.

20.

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.

Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk